<DOC>
	<DOCNO>NCT01192022</DOCNO>
	<brief_summary>The efficacy safety TachoSil速 secondary hemostatic treatment hepatic resection surgery compare standard USA license hemostatic agent , Surgicel速 Original . Hemostatic efficacy evaluate intraoperatively application randomize treatment .</brief_summary>
	<brief_title>TachoSil速 Versus Surgicel速 Original Secondary Treatment Local Bleeding Adult Pediatric Patients Undergoing Hepatic Resection Surgery</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<criteria>Resection least equivalent tissue volume 1 anatomical segment liver Minor moderate ( oozing/diffuse ) bleed resection area persist conventional resection procedure primary control arterial pulsate bleed major venous hemorrhage suture , ligation , clip , vascular stapler , point electrocautery focal radiofrequency ablation Need additional supportive hemostatic treatment Expected ability lightly press trial treatment liver resection wound 3 minute Indication emergency surgery Known coagulopathy ( judge relevant investigator ) Known suspect hypersensitivity ingredient investigational medicinal product ( e.g . human fibrinogen , human thrombin and/or collagen origin ) Patient unwilling receive blood product Known current alcohol drug abuse Pregnancy , breastfeeding , use acceptable contraceptive method female childbearing potential Dry surgical field target application area Occurrence serious surgical complication Disseminated intravascular coagulopathy ( DIC ) , i.e . microvascular bleed Application topical hemostatic material liver resection wound Radiofrequency precoagulation liver resection wound except focal radiofrequency ablation vessel primary hemostatic treatment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Liver resection</keyword>
	<keyword>Liver transplantation</keyword>
	<keyword>Liver surgery</keyword>
	<keyword>Secondary hemostasis</keyword>
</DOC>